These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 34860983)

  • 1. Digital Medicine: Innovative Drug-Device Combination as New Measure of Medication Adherence.
    Vallejos X; Wu C
    J Pharm Technol; 2017 Aug; 33(4):137-139. PubMed ID: 34860983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of an Ingestible, Sensor-Based Digital Adherence System to Strengthen the Therapeutic Relationship in Serious Mental Illness.
    Richey AG; Kovacs I; Browne S
    JMIR Ment Health; 2022 Dec; 9(12):e39047. PubMed ID: 36459392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Low-Power, Low-Cost Ingestible and Wearable Sensing Platform to Measure Medication Adherence and Physiological Signals.
    Weeks WA; Dua A; Hutchison J; Joshi R; Li R; Szejer J; Azevedo RG
    Annu Int Conf IEEE Eng Med Biol Soc; 2018 Jul; 2018():5549-5553. PubMed ID: 30441594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hummingbird Study: a study protocol for a multicentre exploratory trial to assess the acceptance and performance of a digital medicine system in adults with schizophrenia, schizoaffective disorder or first-episode psychosis.
    Fowler JC; Cope N; Knights J; Phiri P; Makin A; Peters-Strickland T; Rathod S
    BMJ Open; 2019 Jun; 9(6):e025952. PubMed ID: 31253613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ingestible electronic sensors to measure instantaneous medication adherence: A narrative review.
    Chai PR; Vaz C; Goodman GR; Albrechta H; Huang H; Rosen RK; Boyer EW; Mayer KH; O'Cleirigh C
    Digit Health; 2022; 8():20552076221083119. PubMed ID: 35251683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of Digital Medicines to Improve Clinical Outcomes in Patients with Uncontrolled Hypertension and Type 2 Diabetes: Prospective, Open-Label, Cluster-Randomized Pilot Clinical Trial.
    Frias J; Virdi N; Raja P; Kim Y; Savage G; Osterberg L
    J Med Internet Res; 2017 Jul; 19(7):e246. PubMed ID: 28698169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First experience with a wireless system incorporating physiologic assessments and direct confirmation of digital tablet ingestions in ambulatory patients with schizophrenia or bipolar disorder.
    Kane JM; Perlis RH; DiCarlo LA; Au-Yeung K; Duong J; Petrides G
    J Clin Psychiatry; 2013 Jun; 74(6):e533-40. PubMed ID: 23842023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing a Digital Medicine System in Psychiatry: Ingestion Detection Rate and Latency Period.
    Profit D; Rohatagi S; Zhao C; Hatch A; Docherty JP; Peters-Strickland TS
    J Clin Psychiatry; 2016 Sep; 77(9):e1095-e1100. PubMed ID: 27379966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hummingbird Study: Results from an Exploratory Trial Assessing the Performance and Acceptance of a Digital Medicine System in Adults with Schizophrenia, Schizoaffective Disorder, or First-Episode Psychosis.
    Fowler JC; Cope N; Knights J; Fang H; Skubiak T; Shergill SS; Phiri P; Rathod S; Peters-Strickland T
    Neuropsychiatr Dis Treat; 2021; 17():483-492. PubMed ID: 33603385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usability of a novel digital medicine system in adults with schizophrenia treated with sensor-embedded tablets of aripiprazole.
    Peters-Strickland T; Pestreich L; Hatch A; Rohatagi S; Baker RA; Docherty JP; Markovtsova L; Raja P; Weiden PJ; Walling DP
    Neuropsychiatr Dis Treat; 2016; 12():2587-2594. PubMed ID: 27785036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digital medicine program with pediatric solid organ transplant patients: Perceived benefits and challenges.
    Triplett KN; El-Behadli AF; Masood SS; Sullivan S; Desai DM
    Pediatr Transplant; 2019 Nov; 23(7):e13555. PubMed ID: 31328842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter, open-label, pilot study evaluating the functionality of an integrated call center for a digital medicine system to optimize monitoring of adherence to oral aripiprazole in adult patients with serious mental illness.
    Kopelowicz A; Baker RA; Zhao C; Brewer C; Lawson E; Peters-Strickland T
    Neuropsychiatr Dis Treat; 2017; 13():2641-2651. PubMed ID: 29089771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digital aripiprazole or digital evergreening? A systematic review of the evidence and its dissemination in the scientific literature and in the media.
    Cosgrove L; Cristea IA; Shaughnessy AF; Mintzes B; Naudet F
    BMJ Evid Based Med; 2019 Dec; 24(6):231-238. PubMed ID: 31320322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilizing an Ingestible Biosensor to Assess Real-Time Medication Adherence.
    Chai PR; Castillo-Mancilla J; Buffkin E; Darling C; Rosen RK; Horvath KJ; Boudreaux ED; Robbins GK; Hibberd PL; Boyer EW
    J Med Toxicol; 2015 Dec; 11(4):439-44. PubMed ID: 26245878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Stability of the Electronic Sensor Component of a Digital Pill System in Real-World Storage Settings.
    Chai PR; Goodman G; Bustamante MJ; Mohamed Y; Castillo-Mancilla J; Boyer EW; Mayer KH; Rosen RK; Baumgartner SL; Buffkin E; O'Cleirigh C
    J Pharm Technol; 2021 Jun; 37(3):135-139. PubMed ID: 34752557
    [No Abstract]   [Full Text] [Related]  

  • 16. Let Visuals Tell the Story: Medication Adherence in Patients with Type II Diabetes Captured by a Novel Ingestion Sensor Platform.
    Browne SH; Behzadi Y; Littlewort G
    JMIR Mhealth Uhealth; 2015 Dec; 3(4):e108. PubMed ID: 26721413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of a medication dose reminder feature in a digital health offering with the use of sensor-enabled medicines.
    Moorhead P; Zavala A; Kim Y; Virdi NS
    J Am Pharm Assoc (2003); 2017; 57(2):155-161.e1. PubMed ID: 28159505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance, Reliability, Usability, and Safety of the ID-Cap System for Ingestion Event Monitoring in Healthy Volunteers: A Pilot Study.
    Flores GP; Peace B; Carnes TC; Baumgartner SL; Buffkin DE; Euliano NR; Smith LN
    Innov Clin Neurosci; 2016; 13(9-10):12-19. PubMed ID: 27974996
    [No Abstract]   [Full Text] [Related]  

  • 19. Feasibility of an ingestible sensor-based system for monitoring adherence to tuberculosis therapy.
    Belknap R; Weis S; Brookens A; Au-Yeung KY; Moon G; DiCarlo L; Reves R
    PLoS One; 2013; 8(1):e53373. PubMed ID: 23308203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct Adherence Measurement Using an Ingestible Sensor Compared With Self-Reporting in High-Risk Cardiovascular Disease Patients Who Knew They Were Being Measured: A Prospective Intervention.
    Thompson D; Mackay T; Matthews M; Edwards J; Peters NS; Connolly SB
    JMIR Mhealth Uhealth; 2017 Jun; 5(6):e76. PubMed ID: 28606895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.